Record $65.3M Revenue, 83% Gross Profit Surge Drive Cosmos Health's Strong FY25 Results; Cash Up 10x
COSM sits 19% above its 52-week low of $0.28.
Summary
Cosmos Health reported robust full-year 2025 financial results, achieving record revenue of $65.3 million, a 20% increase year-over-year. Gross profit surged 83% to $7.9 million, with gross margin expanding by 418 basis points. Notably, the company's cash position increased tenfold to $3.5 million, and adjusted EPS improved by 82%. This strong financial performance aligns with recent positive operational news, including successful product developments and significant purchase orders for its healthcare products. For a company with a relatively small market capitalization, these results demonstrate significant operational leverage and financial strengthening, providing a solid foundation for its stated continued growth into 2026. Traders will monitor the company's ability to sustain this momentum and execute on its expansion initiatives.
At the time of this announcement, COSM was trading at $0.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.5M. The 52-week trading range was $0.28 to $1.32. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Access Newswire.